Treatment and compounds
    2.
    发明授权
    Treatment and compounds 失效
    治疗和化合物

    公开(公告)号:US06531600B1

    公开(公告)日:2003-03-11

    申请号:US09708338

    申请日:2000-11-08

    IPC分类号: C07D239545

    CPC分类号: C07D473/06

    摘要: A method for the treatment of cerebrovascular disorders and/or disorders associated with cerebral senility and/or other disorders which method comprises the administration of an effective, non-toxic amount of a compound of formula (I): or if appropriate a pharmaceutically acceptable salt thereof, wherein R1 and R2 each independently represent alkyl or a moiety of formula (a): —(CH2)m−A   (a) wherein m represents zero or an integer 1, 2 or 3; A represents a substituted or unsubstituted cyclic hydrocarbon radical; and R3 represents a halogen atom, a nitro group, or a group −NR4R5 wherein R4 and R5 each independently represents hydrogen, alkyl or alkylcarbonyl or R4 and R5 together with the nitrogen to which they are attached forming an optionally substituted, heterocyclic group; certain novel compounds falling within formula (I) and compositions comprising such compounds.

    摘要翻译: 用于治疗与脑衰老和/或其他疾病相关的脑血管障碍和/或障碍的方法,所述方法包括施用有效的无毒量的式(I)化合物:或如果合适的话,可药用盐 其中R 1和R 2各自独立地表示烷基或式(a)的部分:其中m表示0或整数1,2或3; A表示取代或未取代的环状烃基; 并且R 3表示卤素原子,硝基或-NR 4 R 5基团,其中R 4和R 5各自独立地表示氢,烷基或烷基羰基或R 4和R 5与它们所连接的氮一起形成任选取代的杂环基; 落在式(I)中的某些新化合物和包含这些化合物的组合物。

    2,4Dioxo-5-arylidenimino-1,3-pyrimidines
    3.
    发明授权
    2,4Dioxo-5-arylidenimino-1,3-pyrimidines 失效
    2,4二氧代-5-亚芳基亚氨基-1,3-嘧啶

    公开(公告)号:US06730787B1

    公开(公告)日:2004-05-04

    申请号:US09869792

    申请日:2001-07-02

    IPC分类号: C07D239545

    CPC分类号: C07D239/545 C07D405/12

    摘要: The invention relates to medicine, and more specifically to pharmacology, and in particular to synthetic biologically active derivatives of pyrimidine, and it is designated mainly for use as antiviral, immune-stimulating, antichlamydial, antituberculous, psychodepressant, analgesic, and hepatoprotective remedies. Besides that, these compounds may be used for treating malignant neoplasms, and also in veterinary. The objective of the invention is obtaining new chemical substances possessing pronounced biological activity of wide range. The proposed objective is achieved by synthesis of 2,4-dioxo-5-arylidenimino-1,3-pyrimidines of the general formula where R is chosen out of group H, OH, alkoxyl, dialkylamino, benzo, dibenzo, or 3,4-dioxolano General method of producing the claimed compounds and example of synthesis, a list of 25 compounds synthesized and tested, results of identification, and data on wide comparative testing their biological properties and toxicity are presented.

    摘要翻译: 本发明涉及药物,更具体地涉及药理学,特别涉及嘧啶的合成生物活性衍生物,其主要用作抗病毒,免疫刺激,抗结肠炎,抗结核药,精神抑郁药,镇痛药和肝脏保护疗法。 此外,这些化合物可用于治疗恶性肿瘤,也可用于兽医。 本发明的目的是获得具有广泛范围的显着生物活性的新化学物质。 所提出的目的是通过合成一般形式的2,4-二氧代-5-亚芳基亚氨基-1,3-嘧啶来实现,其中R选自H,OH,烷氧基,二烷基氨基,苯并,二苯并或3,4- 二氧杂环戊烷生产所要求保护的化合物的一般方法和合成实例,列出了合成和测试的25种化合物的鉴定结果,以及广泛比较测试的数据,其生物学性质和毒性。